Cargando…

Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19

IMPORTANCE: Type 2 diabetes (T2DM) and obesity are significant risk factors for mortality in Covid19. Metformin has sex specific immunomodulatory effects which may elucidate treatment mechanisms in COVID-19. OBJECTIVE: We sought to identify whether metformin reduced mortality from Covid19 and if sex...

Descripción completa

Detalles Bibliográficos
Autores principales: Bramante, Carolyn T., Ingraham, Nicholas E., Murray, Thomas A., Marmor, Schelomo, Hovertsen, Shane, Gronski, Jessica, McNeil, Chace, Feng, Ruoying, Guzman, Gabriel, Abdelwahab, Nermine, King, Samantha, Meehan, Thomas, Pendleton, Kathryn M., Benson, Bradley, Vojta, Deneen, Tignanelli, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325185/
https://www.ncbi.nlm.nih.gov/pubmed/32607520
http://dx.doi.org/10.1101/2020.06.19.20135095
_version_ 1783552103374913536
author Bramante, Carolyn T.
Ingraham, Nicholas E.
Murray, Thomas A.
Marmor, Schelomo
Hovertsen, Shane
Gronski, Jessica
McNeil, Chace
Feng, Ruoying
Guzman, Gabriel
Abdelwahab, Nermine
King, Samantha
Meehan, Thomas
Pendleton, Kathryn M.
Benson, Bradley
Vojta, Deneen
Tignanelli, Christopher J.
author_facet Bramante, Carolyn T.
Ingraham, Nicholas E.
Murray, Thomas A.
Marmor, Schelomo
Hovertsen, Shane
Gronski, Jessica
McNeil, Chace
Feng, Ruoying
Guzman, Gabriel
Abdelwahab, Nermine
King, Samantha
Meehan, Thomas
Pendleton, Kathryn M.
Benson, Bradley
Vojta, Deneen
Tignanelli, Christopher J.
author_sort Bramante, Carolyn T.
collection PubMed
description IMPORTANCE: Type 2 diabetes (T2DM) and obesity are significant risk factors for mortality in Covid19. Metformin has sex specific immunomodulatory effects which may elucidate treatment mechanisms in COVID-19. OBJECTIVE: We sought to identify whether metformin reduced mortality from Covid19 and if sex specific interactions exist. DESIGN: Retrospective review of de-identified claims from UnitedHealth Group’s Clinical Discovery Database. Unadjusted and multivariate models were conducted to assess risk of mortality based on metformin and tumor necrosis factor alpha (TNFα) inhibitors as home medications in individuals with T2DM and obesity, controlling for comorbidities, medications, demographics, and state. Heterogeneity of effect was assessed by sex. SETTING: The database includes all 50 states in the United States. PARTICIPANTS: Persons with at least 6 months of continuous coverage from UnitedHealth Group in 2019 who were hospitalized with Covid-19. Persons in the metformin group had > 90 days of metformin claims in the 12 months before hospitalization. RESULTS: 6,256 persons were included; 52.8% female; mean age 75 years. Metformin was associated with decreased mortality in women by logistic regression, OR 0.792 (0.640, 0.979); mixed effects OR 0.780 (0.631, 0.965); Cox proportional-hazards: HR 0.785 (0.650, 0.951); and propensity matching, OR of 0.759 (0.601, 0.960). There was no significant reduction in mortality among men. TNFα inhibitors were associated with decreased mortality, by propensity matching in a limited model, OR 0.19 (0.0378, 0.983). CONCLUSIONS: Metformin was significantly associated with reduced mortality in women with obesity or T2DM in observational analyses of claims data from individuals hospitalized with Covid-19. This sex-specific finding is consistent with metformin’s reduction of TNFα in females over males, and suggests that metformin conveys protection in Covid-19 through TNFα effects. Prospective studies are needed to understand mechanism and causality.
format Online
Article
Text
id pubmed-7325185
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-73251852020-06-30 Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19 Bramante, Carolyn T. Ingraham, Nicholas E. Murray, Thomas A. Marmor, Schelomo Hovertsen, Shane Gronski, Jessica McNeil, Chace Feng, Ruoying Guzman, Gabriel Abdelwahab, Nermine King, Samantha Meehan, Thomas Pendleton, Kathryn M. Benson, Bradley Vojta, Deneen Tignanelli, Christopher J. medRxiv Article IMPORTANCE: Type 2 diabetes (T2DM) and obesity are significant risk factors for mortality in Covid19. Metformin has sex specific immunomodulatory effects which may elucidate treatment mechanisms in COVID-19. OBJECTIVE: We sought to identify whether metformin reduced mortality from Covid19 and if sex specific interactions exist. DESIGN: Retrospective review of de-identified claims from UnitedHealth Group’s Clinical Discovery Database. Unadjusted and multivariate models were conducted to assess risk of mortality based on metformin and tumor necrosis factor alpha (TNFα) inhibitors as home medications in individuals with T2DM and obesity, controlling for comorbidities, medications, demographics, and state. Heterogeneity of effect was assessed by sex. SETTING: The database includes all 50 states in the United States. PARTICIPANTS: Persons with at least 6 months of continuous coverage from UnitedHealth Group in 2019 who were hospitalized with Covid-19. Persons in the metformin group had > 90 days of metformin claims in the 12 months before hospitalization. RESULTS: 6,256 persons were included; 52.8% female; mean age 75 years. Metformin was associated with decreased mortality in women by logistic regression, OR 0.792 (0.640, 0.979); mixed effects OR 0.780 (0.631, 0.965); Cox proportional-hazards: HR 0.785 (0.650, 0.951); and propensity matching, OR of 0.759 (0.601, 0.960). There was no significant reduction in mortality among men. TNFα inhibitors were associated with decreased mortality, by propensity matching in a limited model, OR 0.19 (0.0378, 0.983). CONCLUSIONS: Metformin was significantly associated with reduced mortality in women with obesity or T2DM in observational analyses of claims data from individuals hospitalized with Covid-19. This sex-specific finding is consistent with metformin’s reduction of TNFα in females over males, and suggests that metformin conveys protection in Covid-19 through TNFα effects. Prospective studies are needed to understand mechanism and causality. Cold Spring Harbor Laboratory 2020-06-28 /pmc/articles/PMC7325185/ /pubmed/32607520 http://dx.doi.org/10.1101/2020.06.19.20135095 Text en https://creativecommons.org/licenses/by-nd/4.0/This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, and only so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Bramante, Carolyn T.
Ingraham, Nicholas E.
Murray, Thomas A.
Marmor, Schelomo
Hovertsen, Shane
Gronski, Jessica
McNeil, Chace
Feng, Ruoying
Guzman, Gabriel
Abdelwahab, Nermine
King, Samantha
Meehan, Thomas
Pendleton, Kathryn M.
Benson, Bradley
Vojta, Deneen
Tignanelli, Christopher J.
Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19
title Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19
title_full Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19
title_fullStr Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19
title_full_unstemmed Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19
title_short Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19
title_sort observational study of metformin and risk of mortality in patients hospitalized with covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325185/
https://www.ncbi.nlm.nih.gov/pubmed/32607520
http://dx.doi.org/10.1101/2020.06.19.20135095
work_keys_str_mv AT bramantecarolynt observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19
AT ingrahamnicholase observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19
AT murraythomasa observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19
AT marmorschelomo observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19
AT hovertsenshane observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19
AT gronskijessica observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19
AT mcneilchace observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19
AT fengruoying observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19
AT guzmangabriel observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19
AT abdelwahabnermine observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19
AT kingsamantha observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19
AT meehanthomas observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19
AT pendletonkathrynm observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19
AT bensonbradley observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19
AT vojtadeneen observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19
AT tignanellichristopherj observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19